Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy
Abstract
Mastocytosis is a clonal disease derived from hematopoietic bone marrow progenitor cells. Clinical manifestations of the disease vary greatly depending on tissue involvement. Omalizumab is a recombinant humanized monoclonal anti-IgE antibody licensed in the treatment of asthma with increasing reports of clinical efficiency in other allergic diseases. We describe a case of a patient with mastocytosis responsive clinically and patho-physiologically after anti-IgE treatment.
Keywords
Mastocytosis, omalizumab, mast cell, skin biopsy, treatment, anti-IgE
Full Text: PDF
No comments:
Post a Comment